Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Janus kinase inhibitor and rituximab in rheumatoid arthritis: is it a safe combination?

Saved in:
Bibliographic Details
Published in:Rheumatology Advances in Practice
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301675730993153
collection WordPress RSS
FRELIP Feed Integration
container_title Rheumatology Advances in Practice
description
discipline_display Rheumatology
discipline_facet Rheumatology
format Online Article
RSS Article
genre Journal Article
id rss_article:58267
institution FRELIP
journal_source_facet Rheumatology Advances in Practice
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Janus kinase inhibitor and rituximab in rheumatoid arthritis: is it a safe combination?
Rheumatology
General
Rheumatology
sub_discipline_display General
sub_discipline_facet General
subject_display Rheumatology
General
Rheumatology
Rheumatology
General
Rheumatology
subject_facet Rheumatology
General
Rheumatology
title Janus kinase inhibitor and rituximab in rheumatoid arthritis: is it a safe combination?
title_auth Janus kinase inhibitor and rituximab in rheumatoid arthritis: is it a safe combination?
title_full Janus kinase inhibitor and rituximab in rheumatoid arthritis: is it a safe combination?
title_fullStr Janus kinase inhibitor and rituximab in rheumatoid arthritis: is it a safe combination?
title_full_unstemmed Janus kinase inhibitor and rituximab in rheumatoid arthritis: is it a safe combination?
title_short Janus kinase inhibitor and rituximab in rheumatoid arthritis: is it a safe combination?
title_sort janus kinase inhibitor and rituximab in rheumatoid arthritis: is it a safe combination?
topic Rheumatology
General
Rheumatology
url https://academic.oup.com/rheumap/article/doi/10.1093/rap/rkag042/8566426?rss=1